Zurcher Kantonalbank (Zurich Cantonalbank) - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$163,500
+14.0%
28,6340.0%0.00%0.0%
Q1 2024$143,456
-44.3%
28,6340.0%0.00%0.0%
Q4 2023$257,420
+26.2%
28,634
+9.1%
0.00%0.0%
Q3 2023$203,916
+6.8%
26,244
+33.0%
0.00%0.0%
Q2 2023$190,996
+14.9%
19,731
+30.1%
0.00%0.0%
Q1 2023$166,230
+134.4%
15,167
-7.6%
0.00%
Q4 2022$70,930
-42.3%
16,4190.0%0.00%
-100.0%
Q3 2022$123,000
-25.5%
16,4190.0%0.00%0.0%
Q2 2022$165,000
-19.5%
16,419
-0.7%
0.00%0.0%
Q1 2022$205,000
-40.9%
16,542
+9.1%
0.00%
-50.0%
Q4 2021$347,000
+26.6%
15,167
+22.7%
0.00%
+100.0%
Q3 2021$274,000
+69.1%
12,3630.0%0.00%0.0%
Q2 2021$162,000
+0.6%
12,3630.0%0.00%0.0%
Q1 2021$161,000
-5.3%
12,3630.0%0.00%0.0%
Q4 2020$170,000
-6.6%
12,3630.0%0.00%0.0%
Q3 2020$182,000
+50.4%
12,363
+66.8%
0.00%0.0%
Q2 2020$121,000
+37.5%
7,410
+21.4%
0.00%0.0%
Q1 2020$88,000
-29.0%
6,1040.0%0.00%0.0%
Q4 2019$124,000
+275.8%
6,1040.0%0.00%
Q3 2019$33,000
-17.5%
6,1040.0%0.00%
Q2 2019$40,0000.0%6,1040.0%0.00%
Q1 2019$40,000
-2.4%
6,1040.0%0.00%
Q4 2018$41,000
+173.3%
6,104
+168.2%
0.00%
Q3 2018$15,000
+275.0%
2,276
+226.1%
0.00%
Q2 2018$4,0006980.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 188,500$4,311,0003.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 334,500$7,647,0001.70%
IRONWOOD INVESTMENT MANAGEMENT LLC 131,760$3,013,0001.49%
NEA Management Company, LLC 3,069,834$70,207,0001.42%
Berry Street Capital Management LLP 575,000$13,151,0001.36%
Melqart Asset Management (UK) Ltd 916,321$20,956,0001.06%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$2,287,0000.93%
HighMark Wealth Management LLC 50,499$1,155,0000.73%
Artal Group S.A. 1,000,000$22,870,0000.62%
Vigilare Wealth Management 34,925$799,0000.47%
View complete list of AURINIA PHARMACEUTICALS INC shareholders